Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
59%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
THNR
19
HOLDINGS
74%
ALSO IN OZEM
OZEM
23
HOLDINGS
67%
ALSO IN THNR
SECTOR DRIFT (THNR minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.4% | 16.8% | 12.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | 8.9% | 12.2% | 8.9% |
|
PFIZER INC | 5.1% | 6.8% | 5.1% |
 |
INNOVENT BIOLOGICS, INC. | 4.7% | 4.7% | 4.7% |
 |
ROCHE HOLDING LTD | 5.7% | 4.4% | 4.4% |
THNR Overweight Relative to OZEM
|
MERCK & CO. INC. | 6.0% |
 |
SHIONOGI & CO LTD | 5.1% |
|
ABBVIE INC | 4.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | 4.0% |
|
AMGEN INC | 3.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.6% |
 |
ASTRAZENECA PLC | 1.9% |
|
SCHOLAR ROCK HOLDING CORP. | 1.6% |
 |
CHINA PHARMACEUTICAL GROUP | 1.4% |
THNR Underweight Relative to OZEM
|
ELI LILLY & CO | -4.5% |
 |
ASCLETIS PHARMA, INC. | -4.1% |
|
NOVO-NORDISK A/S-SPONS ADR | -3.3% |
|
VIKING THERAPEUTICS, INC. | -3.3% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.0% |
 |
HANMI PHARM CO LTD | -2.9% |
|
THE UNITED LABORATORIES INTE | -2.8% |
|
ZEALAND PHARMA A/S | -2.5% |
|
GILEAD SCIENCES INC | -1.9% |
|
PFIZER INC | -1.7% |